We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Biosimilars in oncology in Canada and the role of nurses.
- Authors
Sehdev, Sandeep; Perry, Karyn; Gesy, Kathy
- Abstract
Canadian nurses are familiar with biosimilars in general, but may have knowledge gaps in their specific understanding, resulting in a significant unmet need for education. To assist Canadian nurses in gaining a greater understanding of biosimilars within the oncology treatment landscape and to alleviate certain concerns regarding biosimilar agents, the objectives of this Supplement are to discuss: * biologic drugs in general with an overview of their production * biosimilarity and biosimilars relative to reference biologic drugs * mechanisms of action: biosimilars versus reference biologic drugs * steps to biosimilar development * extrapolation of indications for biosimilars--"totality of evidence" for biosimilars * interchangeability and substitution * Health Canada's approval process for biosimilars * the role of nurses in introducing biosimilars and monitoring patients
- Subjects
CANADA; NURSING education; VASCULAR endothelial growth factor antagonists; DRUG approval laws; ONCOLOGY nursing; CONFERENCES &; conventions; GENERIC drug substitution; GENERIC drugs; HYPERTENSION; MEDICAL protocols; MEDICAL research; NURSE-patient relationships; NURSES; NURSING; ONCOLOGY; PATIENT education; PATIENT monitoring; PATIENT safety; PHARMACEUTICAL industry; TERMS &; phrases; TUMORS; DRUG development; OCCUPATIONAL roles; SOCIAL support; EVIDENCE-based nursing; BEVACIZUMAB; BIOSIMILARS
- Publication
Canadian Oncology Nursing Journal, 2019, Vol 29, p1
- ISSN
1181-912X
- Publication type
Article